Fastest customizable press release news feed in the world
The Company Deepened its Government Relationships at Both State and Federal Levels, Particularly to Support Onshoring Initiatives, While Reinforcing the Strength and Stability of Core Emergency Preparedness Operations Built Momentum Across Several Growth Initiatives with Healthcare and Food Manufacturing Partners SPRING BRANCH, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2025 an
Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications SPRING BRANCH, Texas, March 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics and operational infrastructure company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Biostax Corp ("Biostax"), doing business
Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has agreed with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline, to support its investigational new drug clinical trials for the treatment
SPRING BRANCH, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that Wayne Williams, Chief Executive Officer, Chairman & Founder, has been invited to attend the 50th International GMP Conference, on March 2-5, 2026 in Athens, Georgia. The conference is co-sponsored by the University of Georgia College of Pharmacy and U.S. Food & Drug Administration (FDA). Hosted annually since 1976, the conference offers a global forum where regulatory autho
SPRING BRANCH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. iAccess Alpha Virtual Best Ideas Spring Investment Conference Dates: March 10–11, 2026Location: VirtualPresentation Details: Tuesday, March 10, 2026 at 10:30am ETWebcast Link: https://www.webcaster5.com/Webcast/Page/3157/53626 For more information, please contact your i
SPRING BRANCH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the DealFlow Discovery Conference on January 28-29, 2026. DealFlow Discovery ConferenceDates: January 28-29, 2026Location: The Borgata, Atlantic City, NJPresentation Details: Wednesday, January 28 at 3:00pm, in Room #3 For more information, please contact your DealFlow representative or email KCSA Strategic Communications at [email protected]. About Callan
Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to Enable Immediate Deployment Readiness SPRING BRANCH, TX, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced it has signed a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline. Callan JMB will serve
Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry
Agreement is the latest step in execution of the Company's strategy to support onshoring of logistical and operational activities for international companies to the U.S. SPRING BRANCH, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has entered a preliminary agreement with the maker of an oral drug delivery system to install its innovative manufacturing equipment in Callan JMB's cGMP facility in Texas, while the two companies negotiat
Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable, high-growth consumer markets Spring Branch, TX, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company serving healthcare and emergency management sectors through fulfillment, storage, monitoring, and cold chain logistics, today announced the expansion of its reclamation operations into the food sampling industry. This move is part of Callan JMB's multi-variant strategic growth initiative designed to extend its proven compliance-driven model into adjacent, high-growth markets. Building on a long history of excell
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
4 - CALLAN JMB INC. (0002032545) (Issuer)
8-K - CALLAN JMB INC. (0002032545) (Filer)
8-K - CALLAN JMB INC. (0002032545) (Filer)
SCHEDULE 13G/A - CALLAN JMB INC. (0002032545) (Subject)
8-K - CALLAN JMB INC. (0002032545) (Filer)
8-K - CALLAN JMB INC. (0002032545) (Filer)
8-K - CALLAN JMB INC. (0002032545) (Filer)
8-K - CALLAN JMB INC. (0002032545) (Filer)
Live Leadership Updates
Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries. SPRING BRANCH, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the appointment of former Assistant Commissioner of the Chicago Department of Public Health, Christ
Live finance-specific insights
Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry
Formed a strategic partnership with Revival Health Inc. ("Revival") to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products Launched subsidiary in India and progressed to establish temperature-controlled warehouse for storage and distribution of pharmaceuticals at all temperature ranges Extended long-term contract with City of Chicago and received increase in funding Appointed Christopher Shields, former Assistant Commissioner of the Chicago Department of Public Health, as Senior Vice President, Emergency Preparedness & Response/Government Affairs Supported Texas and New Mex
Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2024, and provided a business update. "2024 was a pivotal year for Callan JMB as we continued to deliver exceptional service to our diverse client base whil